Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed + Cisplatin vs Gemcitabine + Cisplatin in Advanced NSCLC
NCT00087711Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2004
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 27
01
Overview
A Phase 3 trial of pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Eli Lilly and Company. Started Jul 2004; status: completed.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00087711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087711.